ABBOTT LABORATORIES (ABT) earnings date, results and what the price requires
NYSE · SEC CIK 0000001800 · SEC filings checked Oct 16, 2026
Next report
Not yet known
Fewer than three past results filings to estimate from.
Last close
—
No closing price available.
Trailing diluted EPS
$3.57
Sum of quarters ending Mar 31, 2026, Dec 31, 2025, Sep 30, 2025, Jun 30, 2025
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 16, 2026 | Announced; figures arrive with the 10-Q | — | — | Filing |
| Mar 31, 2026 | Apr 16, 2026 | $11.16B | $1.08B | $0.61 | Filing |
| Dec 31, 2025 | Jan 22, 2026 | $11.46B | $1.78B | $1.01 | Filing |
| Sep 30, 2025 | Oct 15, 2025 | $11.37B | $1.64B | $0.94 | Filing |
| Jun 30, 2025 | Jul 17, 2025 | $11.14B | $1.78B | $1.01 | Filing |
| Mar 31, 2025 | Apr 16, 2025 | $10.36B | $1.32B | $0.76 | Filing |
| Dec 31, 2024 | Jan 22, 2025 | $10.97B | $9.23B | $5.26 | Filing |
| Sep 30, 2024 | Oct 16, 2024 | $10.63B | $1.65B | $0.94 | Filing |
| Jun 30, 2024 | Jul 18, 2024 | $10.38B | $1.30B | $0.74 | Filing |
What would ABBOTT LABORATORIES have to report for its valuation to change?
No recent closing price is available for this ticker. The model is not shown rather than filled with assumptions.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.